Anthrax toxin: pathologic effects on the cardiovascular system.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/3382PMID 19273204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anthrax toxin evades Toll‐like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers

  2007cited by this paper
• Catalytically inactive anthrax toxin(s) are potential prophylactic agents.

  2007cited by this paper
• Anthrax Toxins Induce Shock in Rats by Depressed Cardiac Ventricular Function

  2007cited by this paper
• Contributions of Histamine, Prostanoids, and Neurokinins to Edema Elicited by Edema Toxin from Bacillus anthracis

  2007cited by this paper
• LRP5 and LRP6 Are Not Required for Protective Antigen–Mediated Internalization or Lethality of Anthrax Lethal Toxin

  2007cited by this paper
• Anthrax Toxin Receptor 2 Determinants that Dictate the pH Threshold of Toxin Pore Formation

  2007cited by this paper
• Amiodarone and Bepridil Inhibit Anthrax Toxin Entry into Host Cells

  2007cited by this paper
• Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo

  2007cited by this paper
• Anthrax lethal toxin paralyzes actin‐based motility by blocking Hsp27 phosphorylation

  2007cited by this paper
• Mitogen-activated protein kinases in heart development and diseases.

  2007cited by this paper
• Lethal and edema toxins of anthrax induce distinct hemodynamic dysfunction.

  2007cited by this paper
• Stretch-induced MAP kinase activation in cardiac myocytes: differential regulation through beta1-integrin and focal adhesion kinase.

  2007cited by this paper
• Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model.

  2007cited by this paper
• Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses

  2007cited by this paper
• Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

  2007influential reference
• p38 mitogen-activated protein kinase: a future target for heart failure therapy?

  2006cited by this paper
• Synthesis of polyvalent inhibitors of controlled molecular weight: structure-activity relationship for inhibitors of anthrax toxin.

  2006cited by this paper
• The discovery of a potent and selective lethal factor inhibitor for adjunct therapy of anthrax infection.

  2006influential reference
• Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity1

  2006cited by this paper
• JNK1 is required to preserve cardiac function in the early response to pressure overload.

  2006cited by this paper
• The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin.

  2006influential reference
• Anthrax pathogen evades the mammalian immune system through stealth siderophore production

  2006cited by this paper
• Anthrax Toxin Receptor 1/Tumor Endothelium Marker 8 Mediates Cell Spreading by Coupling Extracellular Ligands to the Actin Cytoskeleton*

  2006cited by this paper
• Onset of anthrax toxin pore formation.

  2006cited by this paper
• Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.

  2006cited by this paper
• Regulation of cardiac hypertrophy by intracellular signalling pathways

  2006cited by this paper
• Protective Antigen and Toxin Neutralization Antibody Patterns in Anthrax Vaccinees Undergoing Serial Plasmapheresis

  2005cited by this paper
• The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.

  2005cited by this paper
• Antiplatelet activities of anthrax lethal toxin are associated with suppressed p42/44 and p38 mitogen-activated protein kinase pathways in the platelets.

  2005cited by this paper
• Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.

  2005cited by this paper
• Whole-cell Voltage Clamp Measurements of Anthrax Toxin Pore Current*

  2005cited by this paper
• The detection of protective antigen ( PA ) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions

  2005cited by this paper
• STRESS signaling pathways that modulate cardiac myocyte apoptosis.

  2005cited by this paper
• ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection.

  2005cited by this paper
• Inhibition of Bacillus anthracis growth and virulence-gene expression by inhibitors of quorum-sensing.

  2005cited by this paper
• Calcium‐independent calmodulin binding and two‐metal–ion catalytic mechanism of anthrax edema factor

  2005cited by this paper
• A soluble receptor decoy protects rats against anthrax lethal toxin challenge.

  2005cited by this paper
• Pathophysiological Manifestations in Mice Exposed to Anthrax Lethal Toxin

  2005cited by this paper
• TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen.

  2005cited by this paper
• Anthrax Lethal Toxin Blocks MAPK Kinase-Dependent IL-2 Production in CD4+ T Cells1

  2005cited by this paper
• Identification of Novel Anthrax Lethal Factor Inhibitors Generated by Combinatorial Pictet–Spengler Reaction Followed by Screening in situ

  2005cited by this paper
• Receptor-specific requirements for anthrax toxin delivery into cells.

  2005cited by this paper
• Anthrax Edema Toxin Cooperates with Lethal Toxin to Impair Cytokine Secretion during Infection of Dendritic Cells1

  2005cited by this paper
• Effective antiprotease-antibiotic treatment of experimental anthrax

  2005cited by this paper
• Molecular basis for improved anthrax vaccines.

  2005cited by this paper
• Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.

  2005cited by this paper
• TEM8 interacts with the cleaved C5 domain of collagen alpha 3(VI).

  2004cited by this paper
• Potent inhibitors of anthrax lethal factor from green tea

  2004cited by this paper
• Membrane insertion of anthrax protective antigen and cytoplasmic delivery of lethal factor occur at different stages of the endocytic pathway

  2004cited by this paper
• Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax.

  2004cited by this paper
• Raf-1 Kinase Is Required for Cardiac Hypertrophy and Cardiomyocyte Survival in Response to Pressure Overload

  2004cited by this paper
• MEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo

  2004cited by this paper
• Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis.

  2004cited by this paper
• Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats.

  2004cited by this paper
• The roles of anthrax toxin in pathogenesis.

  2004cited by this paper
• Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to their cognate MAPKs.

  2004influential reference
• Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation.

  2004cited by this paper
• The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor

  2004cited by this paper
• Antitoxins: novel strategies to target agents of bioterrorism

  2004cited by this paper
• TEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI)

  2004cited by this paper
• Cross-inhibition between furin and lethal factor inhibitors.

  2004influential reference
• Stop the killer: how to inhibit the anthrax lethal factor metalloprotease.

  2004cited by this paper
• Lymphocytic vasculitis associated with the anthrax vaccine: case report and review of anthrax vaccination.

  2003cited by this paper
• Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis.

  2003cited by this paper
• Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

  2003cited by this paper
• Bacillus anthracis lethal toxin induces TNF-alpha-independent hypoxia-mediated toxicity in mice.

  2003cited by this paper
• Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor

  2003cited by this paper
• Bacillus anthracis.

  2003cited by this paper
• Molecular recognitions in the MAP kinase cascades.

  2003cited by this paper
• Anthrax Lethal Factor Proteolysis and Inactivation of MAPK Kinase*

  2003cited by this paper
• Anthrax toxin.

  2003cited by this paper
• c‐Jun N‐terminal kinases (JNK) antagonize cardiac growth through cross‐talk with calcineurin–NFAT signaling

  2003cited by this paper
• Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis.

  2003cited by this paper
• LDL receptor relatives at the crossroad of endocytosis and signaling

  2003cited by this paper
• Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.

  2003cited by this paper
• Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models.

  2003cited by this paper
• The Metalloproteolytic Activity of the Anthrax Lethal Factor Is Substrate-inhibited*

  2003cited by this paper
• Bacillus anthracis

  2003cited by this paper
• Binding of Anthrax Toxin to Its Receptor Is Similar to α Integrin-Ligand Interactions*

  2003cited by this paper
• Conformational regulation of integrin structure and function.

  2002cited by this paper
• Structure and function of anthrax toxin.

  2002cited by this paper
• Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York City.

  2002cited by this paper
• Development of an improved vaccine for anthrax.

  2002cited by this paper
• Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin

  2002cited by this paper
• A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease

  2002cited by this paper
• The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.

  2002cited by this paper
• Anthrax

  2002cited by this paper
• Pharmacology: Screening inhibitors of anthrax lethal factor

  2002cited by this paper
• Mapping the Anthrax Protective Antigen Binding Site on the Lethal and Edema Factors*

  2002cited by this paper
• Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.

  2002cited by this paper
• Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons

  2002cited by this paper
• Macrophage Apoptosis by Anthrax Lethal Factor Through p38 MAP Kinase Inhibition

  2002cited by this paper
• In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody.

  2002cited by this paper
• Purification of Anthrax Edema Factor fromEscherichia coli and Identification of Residues Required for Binding to Anthrax Protective Antigen

  2001cited by this paper
• Anthrax Toxin

  2001cited by this paper
• Clinical presentation of inhalational anthrax following bioterrorism exposure: report of 2 surviving patients.

  2001influential reference
• LDL-receptor-related protein 6 is a receptor for Dickkopf proteins

  2001cited by this paper
• Identification of the cellular receptor for anthrax toxin

  2001cited by this paper
• The development of new vaccines against Bacillus anthracis

  2001cited by this paper
• Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme.

  2001cited by this paper

• Decoding Virulence Mechanisms of Bacillus anthracis Using a Galleria mellonella Infection Model: Differential Host Response Profiles Elicited by AtxA and PlcR.

  2026cites this paper
• Recent Advances in Electrochemical Affinity Biosensors: Detection of Biological Toxin Agents.

  2025cites this paper
• 3D-QSAR studies on Pyrido[2,3-d]pyrimidine Derivatives as Fibroblast Growth Factor Receptor 1 Inhibitors: Application of Molecular Field Analysis (MFA)

  2024cites this paper
• Tick-Borne Encephalitis (TBE): From Tick to Pathology

  2023cites this paper
• Pathogenicity and Genomic Characterization of a Novel Genospecies, Bacillus shihchuchen, of the Bacillus cereus Group Isolated from Chinese Softshell Turtle (Pelodiscus sinensis)

  2023cites this paper
• Immunoinformatic design of an epitope-based immunogen candidate against Bacillus anthracis

  2021cites this paper
• Impact of Bacterial Toxins in the Lungs

  2020cites this paper
• Multiple stages of evolutionary change in anthrax toxin receptor expression in humans

  2020cites this paper
• Different mechanisms of two anti-anthrax protective antigen antibodies and function comparison between them

  2019cites this paper
• Anthrax immune globulin improves hemodynamics and survival during B. anthracis toxin-induced shock in canines receiving titrated fluid and vasopressor support

  2017cites this paper
• Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies

  2015cites this paper
• An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis

  2015cites this paper
• Comparative toxicity and efficacy of engineered anthrax lethal toxin variants with broad anti-tumor activities.

  2014cites this paper
• Anthrax lethal and edema toxins in anthrax pathogenesis.

  2014cites this paper
• Anthrax Lethal Toxin Inhibits Translation of Hypoxia-inducible Factor 1α and Causes Decreased Tolerance to Hypoxic Stress*

  2013cites this paper
• Pathology and Pathophysiology of Inhalational Anthrax in a Guinea Pig Model

  2013cites this paper
• B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

  2013cites this paper
• Transcriptome Profiling of Peripheral Blood Cells Identifies Potential Biomarkers for Doxorubicin Cardiotoxicity in a Rat Model

  2012cites this paper
• Functional Characterization of AtxA, the Bacillus anthracis Virulence Regulator

  2012cites this paper
• Investigation of the Biological and Physicochemical Properties of Bacillus anthracis Spores during Germination, Virulence, and Killing

  2012cites this paper
• New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

  2012cites this paper
• New Insights into the Biological Effects of Anthrax Toxins: Linking Cellular to Organismal Responses

  2011cites this paper
• cAMP signaling by anthrax edema toxin induces transendothelial cell tunnels, which are resealed by MIM via Arp2/3-driven actin polymerization.

  2011cites this paper
• The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock

  2011cites this paper
• Diamidodipyrrins as BODIPY dyes and chelator fragment libraries to identify new scaffolds for metalloprotein inhibitors

  2010cites this paper
• Constitutive MEK1 Activation Rescues Anthrax Lethal Toxin-Induced Vascular Effects In Vivo

  2010cites this paper
• A PROTEOMIC ANALYSIS OF NEOPLASTIC PROGRESSION IN BREAST CANCER

  2010cites this paper
• Defining central themes in breast cancer biology by differential proteomics: conserved regulation of cell spreading and focal adhesion kinase.

  2010cites this paper
• Insilico studies on anthrax lethal factor inhibitors: pharmacophore modeling and virtual screening approaches towards designing of novel inhibitors for a killer.

  2010cites this paper
• Current and future medical approaches to combat the anthrax threat.

  2010cites this paper
• Chapter 11 Unexpected Turns and Twists in Structure/Function of PR-Proteins that Connect Energy Metabolism and Immunity

  2009cites this paper